References
- FedericiABCastamanGMannucciPMItalian Association of Hemophilia Centers (AICE). Guidelines for the diagnosis and management of von Willebrand disease in ItalyHaemophilia20028560762112199668
- CastamanGEikenboomJCBertinaRMRodeghieroFInconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigationThromb Haemost19998231065107010494765
- AbbonizioFGiampaoloAArcieriRHassanHJAssociazione Italiana Centri Emofilia (AICE)Registro Nazionale delle Coagulopatie Congenite: Rapporto 2011National Registry of Congenital Coagulopathy: 2011 ReportRomeIstituto Superiore di Sanità2012 Available from: http://www.iss.it/binary/publ/cont/12_55_web.pdfAccessed October 13, 2014
- CastamanGFedericiABRodeghieroFMannucciPMVon Willebrand’s disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatmentHaematologica20038819410812551832
- CastamanGGoodeveAEikenboomJEuropean Group on von Willebrand DiseasePrinciples of care for the diagnosis and treatment of von Willebrand diseaseHaematologica201398566767423633542
- MannucciPMTreatment of von Willebrand’s DiseaseN Engl J Med2004351768369415306670
- PasiKJCollinsPWKeelingDMManagement of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors’ OrganizationHaemophilia200410321823115086319
- JamesPDLillicrapDPThe diagnosis and management of von Willebrand disease in CanadaSemin Thromb Hemost201137552252722102195
- KyrlePAMinarEHirschlMHigh plasma levels of factor VIII and the risk of recurrent venous thromboembolismN Engl J Med2000343745746210950667
- MakrisMColvinBGuptaVSchieldsMLSmithMPVenous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand’s diseaseThromb Haemost200288338738812353065
- MannucciPMVenous thromboembolism in von Willebrand diseaseThromb Haemost200288337837912353063
- FranchiniMKramperaMVeneriDDeep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genesThromb Haemost200390596396414597997
- MauskopfJAPaulJEGrantDMStergachisAThe role of cost- consequence analysis in healthcare decision-makingPharmacoeconomics199813327728810178653
- FreemantleNMasonJNot playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequateBMJ199931871961480148210346779
- DrummondMFSculpherMJTorranceGWO’BrienBJStoddartGLMethods for the Economic Evaluation of Health Care Programmes2nd edOxfordOxford University Press1997
- Bank of ItalyAnnual Report of Bank of Italy on 20125312013
- Bolton-MaggsPHLillicrapDGoudemandJBerntorpEvon Willebrand disease update: diagnostic and treatment dilemmasHaemophilia200814Suppl 3566118510523
- NicholsWLHultinMBJamesAHvon Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)Haemophilia200814217123218315614
- JamesAHKouidesPAAbdul-KadirRVon Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panelAm J Obstet Gynecol2009201112.e1e819481722
- HalimehSKrümpelARottHLong-term secondary prophylaxis in children, adolescents and young adults with von Willebrand disease. Results of a cohort studyThromb Haemost2011105459760421301780
- AbshireTCFedericiABAlvárezMTVWD PNProphylaxis in severe forms of von Willebrand’s disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)Haemophilia2013191768122823000
- BerntorpEPetriniPLong-term prophylaxis in von Willebrand diseaseBlood Coagul Fibrinolysis200516Suppl 1S23S2615849523
- CoppolaACiminoEConcaPLong-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleedingHaemophilia2006121909416409182
- FedericiABGiannielloFMannucciPMSecondary long-term prophilaxis in von Willebrand disease: an Italian cohort studyHaematologica Reports2005161520
- FedericiABHighly purified VWF/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease: the PRO. WILL StudyHaemophilia200713Suppl 5152418078393
- Borel-DerlonAFedericiABRoussel-RobertVTreatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patientsJ Thromb Haemost2007561115112417403090